Cribriform-positive morphology was associated with a 3.6-fold higher risk for metastasis in patients with prostate cancer, and radiotherapy with neoadjuvant androgen deprivation therapy (ADT) was ...

Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that change?

The FDA Just Approved a New Drug for an Aggressive Form of Prostate Cancer — and It Targets the Disease in a Way No Approved ...

*Classification performance AUC and balanced accuracy (mean and std, %) using case-level bags on final tiles with a fixed feature setting and dino cls keep=4. Best result per column in bold. This is ...

AstraZeneca has received US FDA approval for TRUQAP (capivasertib) as the first targeted treatment for PTEN-deficient ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

Pfizer (NYSE:PFE) reported breakthrough Phase 3 results for its BRAFTOVI combination in first-line metastatic colorectal cancer and TALZENNA combination in metastatic hormone-sensitive prostate cancer ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But what does it mean for this type of cancer to be called aggressive? As a ...

A broad study found a link between the use of GLP–1 receptor agonists and a decreased risk of metastatic progression in four ...

Fear can take over the moment prostate cancer progresses. These questions can help caregivers replace confusion with clarity, ...